Continuous prediction for tumor mutation burden based on transcriptional data in gastrointestinal cancers
{{output}}
Background: Tumor mutation burden (TMB) has been considered a biomarker for utilization of immune checkpoint inhibitors(ICIs), but whole exome sequencing(WES) and cancer gene panel(CGP) based on next generation sequencing for TMB... ...
